在维持血液透析期间接受EPO和roxadustat的患者的血红蛋白变异性:一项自我控制研究
1Department of Blood Purification Center, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan Province, China. wpei@zzu.edu.cn.
European review for medical and pharmacological sciences
|January 18, 2024
概括
在血液透析患者中,Roxadustat治疗导致血红蛋白水平升高,并且与红质素相比变异性降低. 这表明roxadustat可以为脏患者提供改善的贫血管理.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學專業.
- 血液学 血液学 血液学
- 药理学 药理学是指药理学的学科.
背景情况:
- 脏贫血是接受维护血液透析 (MHD) 的患者的常见并发症.
- 红色素 (EPO) 等红色素形成刺激剂 (ESA) 是标准的治疗方法,但管理血红蛋白水平可能具有挑战性.
- 罗克萨斯达特是一种新型的低氧诱导因子酸酶抑制剂 (HIF-PHI),提供了另一种治疗方法.
研究的目的:
- 在患有MHD的脏贫血患者中,比较roxadustat与EPO的血红蛋白变异性和疗效.
- 评估roxadustat对关键铁参数的影响,包括血清费里丁和转林和度.
主要方法:
- 一项回顾性自我控制研究从2017年1月到2022年12月分析了80名MHD患者.
- 通过比较治疗前和治疗后的血红蛋白变异性,在roxadustat注射之前和之后评估了血红蛋白变异性.
- 在EPO和roxadustat治疗期间,血清费里丁,转林和和血红蛋白水平进行了比较.
主要成果:
- 与EPO相比,Roxadustat治疗与显著更高的血红蛋白和转红素和水平有关.
- 血红蛋白水平在roxadustat时表现出更快的变化.
- 在roxadustat治疗下,血红蛋白变异性明显低于在EPO治疗下.
结论:
- 罗克萨杜沙特治疗导致更好的血红蛋白控制,在MHD患者中表现为更高的水平和降低的可变性.
- 研究结果表明,与传统的EPO治疗相比,roxadustat可能是治疗脏贫血的更有效选择.
- 由高转林和和铁素表明的最佳铁状况,对于使用roxadustat有效的贫血管理至关重要.
更多相关视频
08:23Characterization of Sickling During Controlled Automated Deoxygenation with Oxygen Gradient Ektacytometry
Published on: November 5, 2019
9.8K
05:23Continuous Manual Exchange Transfusion for Patients with Sickle Cell Disease: An Efficient Method to Avoid Iron Overload
Published on: March 14, 2017
19.5K
相关概念视频
Factors Affecting Erythropoiesis
3.3K
The cardiovascular system regulates the number of erythrocytes in the bloodstream to ensure optimal oxygen transport. It also prevents over-proliferation of these cells, which helps to maintain blood viscosity and flow rate.
Several factors influence the erythrocyte production rate, with tissue oxygen level being among the most critical. Intense exercise or high altitudes can cause tissue hypoxia, which triggers the kidneys to release more erythropoietin (EPO) into the bloodstream.
EPO then...
Several factors influence the erythrocyte production rate, with tissue oxygen level being among the most critical. Intense exercise or high altitudes can cause tissue hypoxia, which triggers the kidneys to release more erythropoietin (EPO) into the bloodstream.
EPO then...
3.3K
Erythropoiesis
4.3K
Red blood cells (RBCs) transport oxygen to all body tissues. These cells survive only for 120 days and then need to be replenished. Erythropoiesis is the process of RBC production. In healthy individuals, erythropoiesis ensures all tissues are amply supplied with oxygen. In addition, blood loss due to injury leads to a drop in the physiological oxygen level that will cause erythropoiesis. Any defect in erythropoiesis leads to several physiological disorders, including thalassemia, anemia,...
4.3K
Disorders of Erythrocytes
940
Disorders of erythrocytes, or red blood cells (RBCs), include a range of conditions affecting their number, shape, or function.
Erythrocyte disorders can be broadly categorized into two main types: anemic and polycythemic conditions.
A low oxygen-carrying capacity of the blood due to the loss, lower production, or destruction of erythrocytes is termed anemia. Hemorrhagic anemia, for example, occurs when bleeding from an external wound or internal ulcer reduces erythrocyte counts.
On the other...
Erythrocyte disorders can be broadly categorized into two main types: anemic and polycythemic conditions.
A low oxygen-carrying capacity of the blood due to the loss, lower production, or destruction of erythrocytes is termed anemia. Hemorrhagic anemia, for example, occurs when bleeding from an external wound or internal ulcer reduces erythrocyte counts.
On the other...
940
Role of Hematopoietic Growth Factors
1.4K
Hematopoietic growth factors are molecules that regulate the differentiation rate of hematopoietic stem cells (HSCs). Erythropoietin (EPO), primarily produced by the kidneys, plays a crucial role in erythrocyte production. When oxygen levels in the blood are low, EPO is released into the bloodstream, reaching the bone marrow, where it stimulates HSCs to differentiate and mature into erythrocytes, which are vital for oxygen transport.
Thrombopoietin (TPO), mainly released by the liver,...
Thrombopoietin (TPO), mainly released by the liver,...
1.4K
Oxygen Transport in the Blood
2.7K
Hemoglobin (Hb) is a crucial molecule in the human body, consisting of four polypeptide chains, each bound to an iron-containing heme group. This unique structure enables hemoglobin to bind to oxygen, with each molecule capable of combining with four molecules of oxygen, leading to rapid and reversible oxygen loading. When fully loaded with oxygen, it is called oxyhemoglobin, while hemoglobin that has released oxygen is called reduced hemoglobin or deoxyhemoglobin. As hemoglobin binds oxygen,...
2.7K
